Drug Database
Back to search

Canada· CA-DIN-02535645

KETAMINE INJECTION, BP

A ketamine product containing ketamine (ketamine hydrochloride), registered in Canada by STERIMAX INC. The same ATC class is registered in 15 of our 19 countries.

ATC N01AX03

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedKETAMINE INJECTION, BPATCN01AX03REGISTER NO.CA-DIN-02535645PACKS LISTED0CHECKEDOctober 1, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ketamine (ketamine hydrochloride)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ketamine is registered in 15 of 19 countries.

Countries holding a registration under ATC N01AX03 (ketamine), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 8 of them publish a price we can compare per daily dose
Search ketamine products by name

Ketamine · ATC N01AX03

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
KETAMINE (KETAMINE HYDROCHLORIDE)
Manufacturer
STERIMAX INC
Country
Canada (CA)
ATC code
N01AX03
ATC class
Ketamine
Defined daily dose
0.25 g, P
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

145 interactions on record for ketamine.

Graded by severity as the source publishes them — 124 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ketamine against other medicinesHow interaction checks work

Ketamine · interactions on record

145 records

  • 124 moderate
  • 21 info

Most severe, free to view

  • EpinephrineA01AD01moderate
  • IsomethepteneA03AX10moderate
  • MetoclopramideA03FA01moderate
  • ThiethylperazinA04AB03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ketamine in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ketamine products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Ketamin G.L., Ketamin, Enthält Benzethoniumchlorid G.L.
  • Belgium · Ketalar
  • Bulgaria · Калипсол
  • Czechia · Calypsol
  • Germany · Ketamin, Ketamin Hameln
  • Denmark · Ketamin Abcur
  • Spain · Ketolar
  • Finland · Ketamin Abcur
  • France · Ketamine G.L. Pharma, Ketamine Panpharma
  • United Kingdom (Northern Ireland) · Ketalar, Ketamine
  • Hungary · Calypsol
  • Ireland · Ketalar
  • Italy · Ketamina Molteni
  • Luxembourg · Ketalar
  • Malta · Ketamine Hydrochloride Inresa
  • Norway · Ketalar, Ketamin Abcur
  • Poland · Ketalar
  • Portugal · Cetamina G.L. Pharma, Cetamina Hikma
  • Romania · Calypsol
  • Sweden · Ketalar, Ketamin Abcur
  • Slovakia · Calypsol

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7fb81289-d4ad-4e1c-8259-62dcb578a9f0
GET /v1/drugs/7fb81289-d4ad-4e1c-8259-62dcb578a9f0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02535645",
  "form": "SOLUTION",
  "class": "Human",
  "routes": [
    "INTRAVENOUS",
    "INTRAMUSCULAR"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "N01AX03",
  "schedule": [
    "Narcotic (CDSA I)"
  ],
  "drug_code": "102449",
  "strengths": [
    "50 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "KETAMINE (KETAMINE HYDROCHLORIDE)"
  ],
  "product_categorization": null
}
API referenceMCP serverPlans

See everything about ketamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console